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Abstract: Canine atopic dermatitis is a common allergic skin disease in dogs caused by defects in immunological and epidermal
barriers. Claudin-1, a protein present in tight junctions, is associated with many skin conditions. Our aim was to investigate expression
levels of claudin-1 and atopic signature cytokines in atopic and normal dog skins. The affected skin showed significantly decreased
intensity and epidermal distribution of claudin-1 compared to the normal control skin (P < 0.05). The CD3+/CD4+ and CD3+/CD8+ T
cell subsets, eosinophils, and neutrophils infiltrated the affected epidermis and dermis. The CD3+/CD4+ T cell subsets in lesional skin
were significantly higher than CD3+/CD8+ T cell subsets. CLDN-1 mRNA expression was markedly downregulated in the lesional skin,
while IL-17A was upregulated in both lesional and nonlesional skin. IL-4 and IL-31 mRNA was upregulated in the lesional skin, and
TNF-α mRNA was significantly upregulated in the nonlesional skin (P < 0.01 and P < 0.05, respectively). Correlation-based hierarchical
clustering showed that CLDN-1 expression was closely clustered with IL-31 but loosely clustered with L-4, IL-10, IL-13, and IL-17A. We
suggest that the alteration of claudin-1 in atopic dogs may disrupt the skin barrier and allow an influx of allergens, inciting inflammatory
cytokine responses.
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1. Introduction
Canine atopic dermatitis is the most common inflammatory
skin disease of dogs (1,2). Many features of this disease are
associated with skin barrier dysfunctions of the epidermis
that are also seen in human atopic dermatitis (1,3,4).
Epidermal composition defects of cross-linked cornified
envelope (CE) proteins, such as filaggrin, involucrin, and
loricrin, can impair skin functions in humans and dogs
with atopic dermatitis (4,5). However, several studies have
shown that skin barrier components found in the stratum
corneum (SC) might have important roles in this defect
(6,7). Tight junctions (TJs), also known as ‘cross-bridged
intercellular contacts’, are the type of junctional complex
located between two neighboring epithelial cells. It has
been documented that many pathological skin conditions
are associated with the changes of TJ morphology and
function (8–10).
Claudin-1, one of the members of TJs present in all
layers of epidermis, is encoded by the CLDN-1 gene. It
is a crucial component of the epidermal morphology
of skin (6,8,10). In mice (8) and humans (10), the
expression of claudin-1 in the epidermis has been seen to
be concentrated in the cell borders of keratinocyte of the
* Correspondence: fvetsrth@ku.ac.th

stratum granulosum (SG) to the stratum basale. In dogs,
claudin-1 is present in all epidermal layers, except the SC
(11), whereas in the SG of canine footpads, its expression
is low (12). Dysfunction of claudin-1 can lead to weak skin
barrier integrity as observed in wrinkled mice (8), dogs
(13), and humans with atopic dermatitis (14). In atopic
skin, the protease activity of house dust mite allergen (Der
p1) cleaves and disrupts claudin-1 (15). Furthermore,
defect of claudin-1 can increase epidermal water loss
from the skin and make it more susceptible to microbial
invasion (16). Recent research suggests that compromised
epidermal TJ barriers are associated with infiltrated T
cells in a cytokine-rich environment (15,16). Decreased
claudin-1 expression in atopic humans is modulated
by the expression of Th-2 cytokines and also regulated
by proinflammatory cytokines in inflammatory skin
conditions (9,14,16). However, regarding epidermal TJ
barriers, in particular, for claudin-1, a correlation between
the protein and mRNA expression levels and atopic
dermatitis in dogs has not yet been established. Therefore,
the aim of this study was to investigate the expression of
claudin-1 in naturally atopic dog skin in association with
the active T cell subsets and their related cytokines. The
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outcome of this study might provide new insight into
pathological invasion via epidermal barrier dysfunction in
canine atopic dermatitis.
2. Materials and methods
2.1. Animal samples
A total of 22 biopsied skin samples were collected from
12 dogs with canine atopic dermatitis (4 Siberian huskies,
3 Golden retrievers, 3 Labrador retrievers, and 2 mongrel
dogs) and 10 normal dogs were used as a control group
(4 Siberian huskies, 4 Golden retrievers, and 2 Labrador
retrievers). None of the atopic dogs had any other related
chronic or systemic skin disease at the time of collection.
The atopic dogs naturally had atopic dermatitis with
chronic pruritus diagnosed by clinical appearance
according to Favrot’s criteria (2). To rule out occurrence of
other skin diseases, cytological examinations for bacterial,
fungal, and yeast infections were carried out. Ectoparasitic
infestations such as flea and sarcoptic mange were excluded.
For final diagnosis, histological examination of skin tissue
was employed to confirm or exclude other inflammatory
or parasitic skin diseases such as demodicosis, cutaneous
lymphoma, or sebaceous adenitis. Atopic dogs were also
withdrawn from steroids or antibiotic drugs for at least
6 weeks prior to the sample collection. The lesions were
assessed according to the CADESI-03 and CADLI scores,
wherein CADESI-03 >23 and CADLI >60 were considered
severe (1,17). A piece of 6 mm in diameter was taken from
lesional and nonlesional skin by punch biopsy based on
the clinical appearance of all atopic dogs. The samples for
immunohistochemistry and gene expression were placed
in 10% neutral buffer formalin and in RNAlater solution
(Ambion, USA), respectively.
This study was approved by the Animal Ethics
Committee of Kasetsart University (ACKU 02956).
All specimens used in this study were collected with
permission from dog owners with informed consent.
2.2. Immunohistochemistry
Tissue sections (3–5 µm) were placed on a positively
charged glass slide (Thermo Scientific, USA) and then
incubated in citrate buffer (pH 6.0) for antigen retrieval.
Primary rabbit anticlaudin-1 antibody (Cell Marque,
USA) was incubated for claudin-1 localization, and
primary rabbit polyclonal anti-CD3 (1:1000) was used
as the first antibody for double immunohistochemistry
(Cell Marque). Mouse monoclonal anti-CD4 (1:200)
(Leica Microsystems, UK) and mouse monoclonal antiCD8 (1:200) (Cell Marque) were incubated separately
for the second staining. Secondary HRP-conjugated goat
antirabbit IgG antibody (Envision DAKO, Denmark) was
used to develop the signals. Immunological reactions
were then detected with diaminobenzidine chromogen
(Invitrogen, UK) and an alkaline phosphatase-conjugated
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goat antimouse IgG antibody (Leica Microsystems)
(1:1000). Vulcan Fast Red Chromogen (BioCare Medical,
USA) was used for visualization.
The evaluation of claudin-1 was carried out with an
Olympus FSX-100 microscope (Olympus, Japan) with 20
fields at 200× magnification. The cellular infiltration was
counted per linear millimeter square of skin. Cell-D digital
image analysis software (Olympus) was used to evaluate
claudin-1 intensity as described previously (4). Statistical
analyses were performed by using the Kruskal–Wallis test
with post hoc Dunn’s test for claudin-1 localization and
one-way ANOVA for cellular infiltration (GraphPad Prism
5.0, USA). P < 0.05 was considered significant.
2.3. RNA extraction and qRT-PCR of CLDN-1 and
cytokine expressions
Total RNA was extracted using TRIzol reagent
(Invitrogen). After removal of DNAse, RNA samples (~1
µg) were reverse-transcribed in order to synthesize cDNA
using a qPCRBIO cDNA synthesis kit (PCR Biosystems,
UK). The mRNA expression levels of CLDN-1 and
cytokine genes were quantitatively measured by realtime quantitative PCR (qPCR) (C1000 Touch Thermal
Cycler, Bio-Rad, USA) using qPCRBIO SyGreen Mix LoROX (PCR Biosystems). Each gene was amplified using
oligonucleotide primer sets, either used previously (3,18)
or newly designed by using Primer3 (v.0.4.0) (Table 1). The
new primer sets were designed based on dog sequences
available in the GenBank database and subsequently
tested against dog genomes (CanFam2.0, Sep 2011
assembly). Housekeeping genes RPS19 and RPLO were
used for normalization (18,19). All evaluations were done
in triplicate. The qPCR data were statistically analyzed
by REST software based on the geometric mean of the
housekeeping genes (20). The patterns and similarity
of gene expression among the samples were analyzed
by MultiExperiment Viewer (MeV) software (version
4.8) (20). The normalized gene expression values were
log2-transformed before hierarchical clustering analysis.
All statistical analyses were performed with a statistical
significance level of P < 0.05.
3. Results
3.1. Claudin-1 localization in atopic and normal control
skins
In immunohistochemistry analysis, the staining patterns
and intensity scores of claudin-1 in the cytoplasmic
membrane of all suprabasal layers appeared to be different
in the normal control skins compared to both lesional
and nonlesional atopic skins. Moreover, intensity scores
of the normal control skins were significantly greater than
those of lesional (P < 0.05) and nonlesional (P < 0.01)
skins (Figure 1; Table 2). In atopic skin, as deduced from
the staining patterns, claudin-1 was significantly reduced
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Table 1. Specific primers for transcript genes and housekeeping genes.
Specific gene
primer

Forward primer
(5’-3’)

Reverse primer
(5’-3’)

Accession number

Product size (bp)

IFN-γ

ccgactaggcaagactgtga

cagtggctcatcatgcagac

NM_001003174.1

177

TNF-α

actggagaagggtgatcgac

gtttgggcaagaatggacgt

NM_001003244.4

129

TGF-β1

atgttgtttttcggggacag

atgttgtttttcggggacag

NM_001003309.1

245

IL-4

cactcaccagcacctttgtc

aggtcttgtttgccatgctg

AF187322.1

264

IL-10

gctccaggagaaaggtgtct

agagagaggtatgacggggt

NM_001003077.1

230

IL-13

gtcttgctgtacctgggagt

gcagacaagagcagcatctc

NM_001003384.1

246

IL-17A

tacccctctgtgatctggga

catggcgaacaataggggtg

AB514445.1

208

IL-31

cctgttcctgctctgctcta

tgagacacagcagcaaggta

NM_001165914.1

188

CLDN-1

catggcgaacaataggggtg

atgttgtttttcggggacag

XM_845155.2

284

RPS19

ccttcctcaaaaagtctggg

gttctcatcgtagggagcaag

XM_533657

95

RPLO

ttgtggctgctgctcctgtg

atcctcgtccgattcctccg

XM_003433128.1

107

Nonlesional
Figure 1. Claudin-1 localization in the biopsied skins: normal skin (A) and the lesional (B) and nonlesional (C) atopic
dog skins (immunohistochemical staining, bar = 50 µm). Claudin-1 intensity score is given as mean ± SEM (a = P <
0.05, b = P < 0.01).
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Table 2. Inflammatory infiltrating cells and claudin-1 intensity scores in the atopic and normal control skins.
Group

CD3+/CD4+
T cells

CD3+/CD8+
T cells

Claudin-1
staining score

Neutrophils
(cells/mm2)

Eosinophils
(cells/mm2)

All atopic dogs
(n = 12)

403.01 ± 153.10c

176.9 ± 91.85c

0.86 ± 0.30a

43.52 ± 21.54c

54.05 ± 42.19b

Atopic dogs with CADESI <120
and CADLI <23 (n = 6)

393.40 ± 95.73a

174.30 ± 70.46b

0.84 ± 0.30a

37.73 ± 16.12c

47.42 ± 39.50b

Atopic dogs with CADESI >120
and CADLI >23 (n = 6)

438.10 ± 147.10b

172.00 ± 67.85b

0.88 ± 0.34a

49.32 ± 27.07c

60.67 ± 49.76c

Normal control dogs (n = 10)

12.57 ± 5.31

10.02 ± 4.89

3.79 ± 0.32

1.64 ± 1.94

0.84 ± 1.18

The values are presented as mean ± SEM. Values within a column followed by different letters are significantly different when compared
with those of the normal control skins (a = P < 0.05, b = P < 0.01, c = P < 0.001).

in the cytoplasmic membrane of the SG and the stratum
spinosum. A discontinuous staining pattern, particularly
in the area of parakeratotic and spongiotic lesions, was
found. However, there was no significant difference in the
staining score of claudin-1 between the lesional and the
nonlesional skins or between the atopic dogs with a higher
clinical score (CADESI-03 >120; CADLI >60) and those
with a lower clinical score (CADESI-03 <120; CADLI <60)
(P > 0.05).
3.2. Cellular infiltration in the canine atopic dermatitis
and normal control skins
Populations of inflammatory infiltrating cells (neutrophils,
eosinophils, T cell subpopulations of CD3+/CD4+ T
cells, and CD3+/CD8+ T cell subsets) were determined
(Figure 2; Table 2). The CD3+/CD4+ and CD3+/CD8+ T
cell numbers were significantly increased in lesional and
nonlesional skins compared to the normal control group
with P < 0.01 and P < 0.05, respectively. It should be noted
that the numbers of the CD3+/CD4+ T cell sub-subset were
significantly greater than those of the CD3+/CD8+ T cell
sub-subset in atopic skin. The neutrophil and eosinophil
numbers increased and were occasionally accompanied by
microaggregation in the lesional skin (data not shown).
3.3. mRNA expression and hierarchical clustering
analysis
The expression level of the CLDN-1 gene in lesional
skins was significantly lower than in normal skins (P
= 0.032) with a 0.033-fold change indicating a marked
downregulation of the gene in the lesional skins. In
addition, the expression levels of IL-4, IL-17A, and IL31 were significantly greater in the lesional skins than in
normal control skins with 4.932-fold (P = 0.002), 6.644fold (P = 6.644), and 10.525-fold (P = 10.525) changes,
respectively. TNF-α and IL-17 in the nonlesional skins
were significantly higher than in normal skins with 4.324-
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fold (P = 0.042) and 9.243-fold (P = 0.020) changes. There
were no significant differences between the lesional and
nonlesional skins. These results indicated that the CLDN-1
gene is downregulated in atopic dermatitis, especially in
lesional skins. This was confirmed by the increase in some
of the cytokines of the proinflammatory T cells (Table 3).
Hierarchical clustering analysis showed that there were
two main clusters of the gene expression pattern (Figure
3): 1) TNF-α, TGF-β1, and IFN-γ, and 2) IL-4, IL-10,
IL-13, IL-3, IL-17A, and CLDN-1. This indicates that a
significant degree of mRNA coexpression was observable,
particularly in this condition. Moreover, CLDN-1, a major
gene associated with TJs, was more closely related to IL-31
than other cytokines within the same subcluster.
4. Discussion
This study is the first report characterizing the expression
of claudin-1 within TJs in dogs with atopic dermatitis by
measuring the presence of claudin-1 protein and CLDN-1
gene expression. Immunohistochemistry indicated that the
location of claudin-1 in the normal dog skins was similar
to that of healthy skins of humans (6), mice (8), and other
dogs (11). The staining score of claudin-1 was significantly
reduced in both lesional and nonlesional skins compared
to the normal control. This observation was confirmed by
measuring the gene expression level of CLDN-1 in each of
the dogs studied. Our results indicate that the claudin-1
protein corresponds to the first skin barrier protection,
similar to earlier reports in dogs (13) and humans (14–
16). It should be noted that allergens could easily penetrate
into deeper epidermal layers due to defects in the first skin
barrier at low levels of SC and CE proteins (7,14,15). In
addition, the expression of CE proteins was significantly
reduced in atopic dogs (4). However, an alternation in SC
lipid composition and filaggrin protein in humans with
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Nonlesional

Nonlesional
Figure 2. Double immunohistochemistry of CD3+/CD4+ (A) and CD3+/CD8+ T cell subsets (B) demonstrating
infiltration into the epidermis and diffused aggregation in the dermis. Colocalization of all positive T cells is presented
in the insets (CD3+ in brown color and CD4+, CD8+ in red color, double immunohistochemical stain, bar = 50 µm).
Numbers of each T cell subset are compared between biopsied samples (a = P < 0.05, b = P < 0.01).
Table 3. Fold change in specific mRNA expressions in the atopic and normal control skins.
Gene

Lesional atopic vs. normal

Nonlesional atopic vs. normal

Lesional vs. nonlesional atopic

Fold change

P-values

Fold change

P-values

Fold change

P-values

IFN-γ

1.422

NS

1.662

NS

0.855

NS

TNF-α

2.462

NS

4.324

0.042

0.569

NS

TGF-β1

0.002

NS

0.692

NS

0.003

NS

IL-4

4.932

0.002

1.923

NS

2.554

NS

IL-10

0.775

NS

0.735

NS

1.053

NS

IL-13

1.507

NS

0.554

NS

2.720

NS

IL-17A

6.644

0.002

9.243

0.020

0.718

NS

IL-31

10.525

0.001

1.834

NS

5.740

NS

CLDN-1

0.033

0.032

0.582

NS

0.572

NS

A pair-wise fixed reallocation test (REST) was normalized by the geometric mean of two housekeeping genes, RPS19 and RPLO. Values
in bold indicate significant difference at α = 0.05. NS = nonsignificant.
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Nonlesional

Figure 3. Hierarchical clustering for grouping of mRNA expressions of the biopsied samples: CLDN-1 =
claudin-1, IFN-γ = interferon-gamma, IL-4 = interleukin-4, IL-10 = interleukin-10, IL-17A = interleukin17A, IL-31 = interleukin-31, TNF-α = tumor necrotic factor-alpha, and TGF-β1 = transforming growth
factor-beta 1.

atopy and psoriasis has also been reported (7,10). Several
studies have documented that deficiency of claudin-1 is
associated with epidermal water loss in mice (8). Decreased
claudin-1 protein expression has been recently reported in
atopic dogs, but the other TJs, such as ZO-1 and occludin,
did not show any association (13). Moreover, in contrast
to earlier studies, the mRNA expression level of CLDN-1
was not significant in small-breed dogs (3). One possible
reason is that the TJ expression in genetic-associated
diseases might be more clearly noticed in purebred dogs.
Further study is required with a larger sample size to
confirm these results.
In this study, numbers of CD3+/CD4+ T cells were
significantly greater than numbers of CD3+/CD8+ T cells
in atopic skin. This could be explained by the presence of
eosinophils and Th1/Th2-producing cells in response to the
inflammatory response (21). This relatively high Th2 cell
number was also observed in pruritic dogs with increased
IL-4 mRNA level (22). As an effect of immunological
response, increased levels of some cytokines, e.g., IL-4, IL17A, and IL-31, associated with the depletion of CLDN-1
in atopic skin, were also found. Filaggrin expression can
be downregulated by IL-7 stimulation in keratinocytes.
Moreover, the effect of this IL-7 has been shown in
reducing transcription of TJ proteins including the claudin
family, ZO-1, plankoglobins, plakophilins, and cadherins
(23,24). This suggests that IL-17A-dominated cytokine
expression in atopic skin disease can promote skin barrier
dysfunction. We found that neutrophil aggregation in the
nonlesional skins might be associated with the synergistic
effects of IL-17A and TNF-α on continued inflammation
and neutrophil recruitment (25). The upregulation of TJ
requires TNF-α to increase transepidermal resistance in
the early stage of psoriatic skin (9). Therefore, the effect
of TNF-α alone could have indirectly affected CLDN-1
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mRNA levels in the nonlesional skins in our study. Several
studies reported increasing levels of IFN-γ and IL-10 in
chronic atopic dermatitis in humans (25,26). However,
we could not see any difference in these two parameters
between dogs with atopic dermatitis and normal dogs,
as we considered that dogs with atopic dermatitis in this
study were in the acute phase.
IL-31 mRNA level was significantly greater in the
lesional atopic skins compared to the normal control,
as shown in Table 3. The same results were reported in
human atopic skins with higher levels of Th2 rather than
Th1 cells (27,28) and were also observed in pruritic dogs
(22,29). Therefore, IL-31 can be an important indicator
of immunological response in atopic disease. According
to the hierarchical clustering, CLDN-1 expression can be
used to confirm the relevance of several cytokines as the
indicator of gene coexpression partners in atopic skin.
This is the first report showing a relationship between
claudin-1 and inflammatory cytokines in atopic dog
skins compared to normal skins. Our results suggest that
claudin-1 may play an important role in the first skin barrier
protection and could be used as a potential indicator for
canine atopic dermatitis in the future. Further study with
a larger sample size would be important to confirm the
results presented in this study.
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